{"id":4624,"date":"2019-11-01T10:45:12","date_gmt":"2019-11-01T09:45:12","guid":{"rendered":"http:\/\/www.epitype.de\/?p=4624&#038;lang=en"},"modified":"2020-10-09T14:16:14","modified_gmt":"2020-10-09T12:16:14","slug":"oncgnostics-expands-business-relations-in-asia","status":"publish","type":"post","link":"https:\/\/www.epitype.de\/en\/blog\/2019\/11\/01\/oncgnostics-expands-business-relations-in-asia\/","title":{"rendered":"Oncgnostics Expands Business Relations in Asia"},"content":{"rendered":"<h1><strong>Approval for cervical cancer screening test in the Chinese market expected in early 2020 \/ First contacts in Japan<\/strong><\/h1>\n<p><strong>Shanghai\/Yokohama\/Tokyo\/Jena, 1 November 2019 \u2013Our business partner in China, <\/strong><a href=\"http:\/\/www.geneodx.com\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>GeneoDx<\/strong><\/a><strong>, is about to get approval to commercialise GynTect in the Chinese market. This issue was discussed at a business meeting with representatives from <\/strong><a href=\"http:\/\/www.epitype.de\/\" target=\"_blank\" rel=\"noopener\"><strong>oncgnostics GmbH <\/strong><\/a><strong>in Shanghai.<\/strong><\/p>\n<p>Our Chinese business partner GeneoDx, a SINOPHARM subsidiary, presented oncgnostics&#8217; managing directors, Dr Martina Schmitz and Dr Alfred Hansel, in Shanghai with the results of their recently completed approval study for the National Medical Products Administration (NMPA) for the molecular biological test GynTect. The approval of GynTect for the Chinese market is expected in early 2020. The test allows reliable and rapid diagnosis of cervical cancer and its precancerous stages.<\/p>\n<p>&#8216;Our partners have conducted a study with approximately 1,300 samples. Results look very promising. We are optimistic that GeneoDx will receive approval for GynTect without any problems. Moreover, the study will be followed by high-ranking publications,&#8217; states oncgnostics&#8217; managing director Martina Schmitz.<\/p>\n<p>Dr Alfred Hansel visited <a href=\"https:\/\/www.ics-expo.jp\/biojapan\/en\/\" target=\"_blank\" rel=\"noopener noreferrer\">BioJapan<\/a> in Yokohama, Japan. At the conference, he cultivated existing contacts, which he had made during a visit to MedTech Japan in Tokyo <a href=\"http:\/\/www.epitype.de\/blog\/2019\/03\/29\/gebaermutterhalskrebsvorsorge-in-japan\/\" target=\"_blank\" rel=\"noopener\">earlier this year<\/a>. He also held discussions with other companies on the marketing opportunities of GynTect in Japan and other countries in Southeast Asia.<\/p>\n<p>The Asian market is interesting for oncgnostics not only with regard to GynTect. International partnerships are also being sought for current pipeline projects, in particular the development of assays in the field of head and neck tumour diagnostics.<\/p>\n<h2><strong>About oncgnostics:<\/strong><\/h2>\n<p>Jena&#8217;s oncgnostics GmbH specialises in the early detection of cancer. Its tests detect changes that are characteristic of cancer cells&#8217; DNA. Founded in 2012, the company launched GynTect in 2015. As part of its programme for the early detection of cervical cancer, the test clarifies whether cervical cancer or precancerous lesions are already present. In April 2017, GeneoDx and oncgnostics signed an <a href=\"http:\/\/www.epitype.de\/blog\/2017\/04\/06\/gyntect-bald-in-china-verfuegbar-oncgnostics-erteilt-exklusive-lizenz-an-chinesische-sinopharm-tochter\/\" target=\"_blank\" rel=\"noopener\">exclusive license agreement for GynTect <\/a>in China, Hong Kong, and Macau.<\/p>\n<p>Oncgnostics GmbH is also conducting research into tests for the clarification of other types of cancer. Detailed information is available at <a href=\"http:\/\/www.epitype.de\" target=\"_blank\" rel=\"noopener\">www.oncgnostics.com<\/a>.<\/p>\n<h2><strong>About GynTect:<\/strong><\/h2>\n<p>GynTect is a molecular biological test that identifies six areas of the human genome that are methylated only during the development of cancer cells. Thus, GynTect recognises malignant changes in patients.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Approval for cervical cancer screening test in the Chinese market expected in early 2020 \/ First contacts in Japan Shanghai\/Yokohama\/Tokyo\/Jena, 1 November 2019 \u2013Our business partner in China, GeneoDx, is [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":3286,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[59],"tags":[472,490,487,480,464],"class_list":["post-4624","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-releases","tag-china-en","tag-dr-alfred-hansel-en","tag-dr-martina-schmitz-en","tag-geneodx-en","tag-gyntect-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Oncgnostics Expands Business Relations in Asia - Epitype GmbH<\/title>\n<meta name=\"description\" content=\"Approval for cervical cancer screening test GynTect in the Chinese market expected in early 2020 \/ First contacts in Japan\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.epitype.de\/en\/blog\/2019\/11\/01\/oncgnostics-expands-business-relations-in-asia\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Oncgnostics Expands Business Relations in Asia - Epitype GmbH\" \/>\n<meta property=\"og:description\" content=\"Approval for cervical cancer screening test GynTect in the Chinese market expected in early 2020 \/ First contacts in Japan\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.epitype.de\/en\/blog\/2019\/11\/01\/oncgnostics-expands-business-relations-in-asia\/\" \/>\n<meta property=\"og:site_name\" content=\"Epitype GmbH\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/oncgnostics\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-11-01T09:45:12+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-10-09T12:16:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.epitype.de\/wp-content\/uploads\/2018\/04\/Geneo_Dx_sm.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1440\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Admin Spinger\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Admin Spinger\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.epitype.de\\\/en\\\/blog\\\/2019\\\/11\\\/01\\\/oncgnostics-expands-business-relations-in-asia\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.epitype.de\\\/en\\\/blog\\\/2019\\\/11\\\/01\\\/oncgnostics-expands-business-relations-in-asia\\\/\"},\"author\":{\"name\":\"Admin Spinger\",\"@id\":\"https:\\\/\\\/www.epitype.de\\\/en\\\/#\\\/schema\\\/person\\\/d7a079bc842189ef46127cbaa3c6bd32\"},\"headline\":\"Oncgnostics Expands Business Relations in Asia\",\"datePublished\":\"2019-11-01T09:45:12+00:00\",\"dateModified\":\"2020-10-09T12:16:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.epitype.de\\\/en\\\/blog\\\/2019\\\/11\\\/01\\\/oncgnostics-expands-business-relations-in-asia\\\/\"},\"wordCount\":390,\"image\":{\"@id\":\"https:\\\/\\\/www.epitype.de\\\/en\\\/blog\\\/2019\\\/11\\\/01\\\/oncgnostics-expands-business-relations-in-asia\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.epitype.de\\\/wp-content\\\/uploads\\\/2018\\\/04\\\/Geneo_Dx_sm.jpg\",\"keywords\":[\"China\",\"Dr. Alfred Hansel\",\"Dr. Martina Schmitz\",\"GeneoDx\",\"GynTect\"],\"articleSection\":[\"Press Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.epitype.de\\\/en\\\/blog\\\/2019\\\/11\\\/01\\\/oncgnostics-expands-business-relations-in-asia\\\/\",\"url\":\"https:\\\/\\\/www.epitype.de\\\/en\\\/blog\\\/2019\\\/11\\\/01\\\/oncgnostics-expands-business-relations-in-asia\\\/\",\"name\":\"Oncgnostics Expands Business Relations in Asia - Epitype GmbH\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.epitype.de\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.epitype.de\\\/en\\\/blog\\\/2019\\\/11\\\/01\\\/oncgnostics-expands-business-relations-in-asia\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.epitype.de\\\/en\\\/blog\\\/2019\\\/11\\\/01\\\/oncgnostics-expands-business-relations-in-asia\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.epitype.de\\\/wp-content\\\/uploads\\\/2018\\\/04\\\/Geneo_Dx_sm.jpg\",\"datePublished\":\"2019-11-01T09:45:12+00:00\",\"dateModified\":\"2020-10-09T12:16:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.epitype.de\\\/en\\\/#\\\/schema\\\/person\\\/d7a079bc842189ef46127cbaa3c6bd32\"},\"description\":\"Approval for cervical cancer screening test GynTect in the Chinese market expected in early 2020 \\\/ First contacts in Japan\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.epitype.de\\\/en\\\/blog\\\/2019\\\/11\\\/01\\\/oncgnostics-expands-business-relations-in-asia\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.epitype.de\\\/en\\\/blog\\\/2019\\\/11\\\/01\\\/oncgnostics-expands-business-relations-in-asia\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.epitype.de\\\/en\\\/blog\\\/2019\\\/11\\\/01\\\/oncgnostics-expands-business-relations-in-asia\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.epitype.de\\\/wp-content\\\/uploads\\\/2018\\\/04\\\/Geneo_Dx_sm.jpg\",\"contentUrl\":\"https:\\\/\\\/www.epitype.de\\\/wp-content\\\/uploads\\\/2018\\\/04\\\/Geneo_Dx_sm.jpg\",\"width\":1440,\"height\":1080,\"caption\":\"The oncgnostics managers together with Geneo Dx managers and colleagues.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.epitype.de\\\/en\\\/blog\\\/2019\\\/11\\\/01\\\/oncgnostics-expands-business-relations-in-asia\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.epitype.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oncgnostics Expands Business Relations in Asia\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.epitype.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.epitype.de\\\/en\\\/\",\"name\":\"epitype GmbH\",\"description\":\"Molecular cancer diagnostics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.epitype.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.epitype.de\\\/en\\\/#\\\/schema\\\/person\\\/d7a079bc842189ef46127cbaa3c6bd32\",\"name\":\"Admin Spinger\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2bdf63918742a3702c1fc24be733bef919a10bb3d0388a3236cf3a0f419b9461?s=96&d=blank&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2bdf63918742a3702c1fc24be733bef919a10bb3d0388a3236cf3a0f419b9461?s=96&d=blank&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2bdf63918742a3702c1fc24be733bef919a10bb3d0388a3236cf3a0f419b9461?s=96&d=blank&r=g\",\"caption\":\"Admin Spinger\"},\"url\":\"https:\\\/\\\/www.epitype.de\\\/en\\\/blog\\\/author\\\/admin-spinger\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Oncgnostics Expands Business Relations in Asia - Epitype GmbH","description":"Approval for cervical cancer screening test GynTect in the Chinese market expected in early 2020 \/ First contacts in Japan","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.epitype.de\/en\/blog\/2019\/11\/01\/oncgnostics-expands-business-relations-in-asia\/","og_locale":"en_US","og_type":"article","og_title":"Oncgnostics Expands Business Relations in Asia - Epitype GmbH","og_description":"Approval for cervical cancer screening test GynTect in the Chinese market expected in early 2020 \/ First contacts in Japan","og_url":"https:\/\/www.epitype.de\/en\/blog\/2019\/11\/01\/oncgnostics-expands-business-relations-in-asia\/","og_site_name":"Epitype GmbH","article_publisher":"https:\/\/www.facebook.com\/oncgnostics\/","article_published_time":"2019-11-01T09:45:12+00:00","article_modified_time":"2020-10-09T12:16:14+00:00","og_image":[{"width":1440,"height":1080,"url":"https:\/\/www.epitype.de\/wp-content\/uploads\/2018\/04\/Geneo_Dx_sm.jpg","type":"image\/jpeg"}],"author":"Admin Spinger","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Admin Spinger","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.epitype.de\/en\/blog\/2019\/11\/01\/oncgnostics-expands-business-relations-in-asia\/#article","isPartOf":{"@id":"https:\/\/www.epitype.de\/en\/blog\/2019\/11\/01\/oncgnostics-expands-business-relations-in-asia\/"},"author":{"name":"Admin Spinger","@id":"https:\/\/www.epitype.de\/en\/#\/schema\/person\/d7a079bc842189ef46127cbaa3c6bd32"},"headline":"Oncgnostics Expands Business Relations in Asia","datePublished":"2019-11-01T09:45:12+00:00","dateModified":"2020-10-09T12:16:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.epitype.de\/en\/blog\/2019\/11\/01\/oncgnostics-expands-business-relations-in-asia\/"},"wordCount":390,"image":{"@id":"https:\/\/www.epitype.de\/en\/blog\/2019\/11\/01\/oncgnostics-expands-business-relations-in-asia\/#primaryimage"},"thumbnailUrl":"https:\/\/www.epitype.de\/wp-content\/uploads\/2018\/04\/Geneo_Dx_sm.jpg","keywords":["China","Dr. Alfred Hansel","Dr. Martina Schmitz","GeneoDx","GynTect"],"articleSection":["Press Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.epitype.de\/en\/blog\/2019\/11\/01\/oncgnostics-expands-business-relations-in-asia\/","url":"https:\/\/www.epitype.de\/en\/blog\/2019\/11\/01\/oncgnostics-expands-business-relations-in-asia\/","name":"Oncgnostics Expands Business Relations in Asia - Epitype GmbH","isPartOf":{"@id":"https:\/\/www.epitype.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.epitype.de\/en\/blog\/2019\/11\/01\/oncgnostics-expands-business-relations-in-asia\/#primaryimage"},"image":{"@id":"https:\/\/www.epitype.de\/en\/blog\/2019\/11\/01\/oncgnostics-expands-business-relations-in-asia\/#primaryimage"},"thumbnailUrl":"https:\/\/www.epitype.de\/wp-content\/uploads\/2018\/04\/Geneo_Dx_sm.jpg","datePublished":"2019-11-01T09:45:12+00:00","dateModified":"2020-10-09T12:16:14+00:00","author":{"@id":"https:\/\/www.epitype.de\/en\/#\/schema\/person\/d7a079bc842189ef46127cbaa3c6bd32"},"description":"Approval for cervical cancer screening test GynTect in the Chinese market expected in early 2020 \/ First contacts in Japan","breadcrumb":{"@id":"https:\/\/www.epitype.de\/en\/blog\/2019\/11\/01\/oncgnostics-expands-business-relations-in-asia\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.epitype.de\/en\/blog\/2019\/11\/01\/oncgnostics-expands-business-relations-in-asia\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.epitype.de\/en\/blog\/2019\/11\/01\/oncgnostics-expands-business-relations-in-asia\/#primaryimage","url":"https:\/\/www.epitype.de\/wp-content\/uploads\/2018\/04\/Geneo_Dx_sm.jpg","contentUrl":"https:\/\/www.epitype.de\/wp-content\/uploads\/2018\/04\/Geneo_Dx_sm.jpg","width":1440,"height":1080,"caption":"The oncgnostics managers together with Geneo Dx managers and colleagues."},{"@type":"BreadcrumbList","@id":"https:\/\/www.epitype.de\/en\/blog\/2019\/11\/01\/oncgnostics-expands-business-relations-in-asia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.epitype.de\/en\/"},{"@type":"ListItem","position":2,"name":"Oncgnostics Expands Business Relations in Asia"}]},{"@type":"WebSite","@id":"https:\/\/www.epitype.de\/en\/#website","url":"https:\/\/www.epitype.de\/en\/","name":"epitype GmbH","description":"Molecular cancer diagnostics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.epitype.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.epitype.de\/en\/#\/schema\/person\/d7a079bc842189ef46127cbaa3c6bd32","name":"Admin Spinger","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/2bdf63918742a3702c1fc24be733bef919a10bb3d0388a3236cf3a0f419b9461?s=96&d=blank&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2bdf63918742a3702c1fc24be733bef919a10bb3d0388a3236cf3a0f419b9461?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2bdf63918742a3702c1fc24be733bef919a10bb3d0388a3236cf3a0f419b9461?s=96&d=blank&r=g","caption":"Admin Spinger"},"url":"https:\/\/www.epitype.de\/en\/blog\/author\/admin-spinger\/"}]}},"_links":{"self":[{"href":"https:\/\/www.epitype.de\/en\/wp-json\/wp\/v2\/posts\/4624","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.epitype.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.epitype.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.epitype.de\/en\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/www.epitype.de\/en\/wp-json\/wp\/v2\/comments?post=4624"}],"version-history":[{"count":0,"href":"https:\/\/www.epitype.de\/en\/wp-json\/wp\/v2\/posts\/4624\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.epitype.de\/en\/wp-json\/wp\/v2\/media\/3286"}],"wp:attachment":[{"href":"https:\/\/www.epitype.de\/en\/wp-json\/wp\/v2\/media?parent=4624"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.epitype.de\/en\/wp-json\/wp\/v2\/categories?post=4624"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.epitype.de\/en\/wp-json\/wp\/v2\/tags?post=4624"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}